Brief: Biocartis Announces CE-Marking Of Its Idylla SARS-CoV-2 Test
10/11/2020 06:10
Nov 10 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* PRESS NEWS BIOCARTIS GROUP NV: BIOCARTIS ANNOUNCES
CE-MARKING OF
ITS FULLY AUTOMATED IDYLLA™ SARS-COV-2 TEST
* TEST IS INTENDED TO DETECT SARS-COV-2 FROM NASOPHARYNGEAL
SWABS
IN VIRAL TRANSPORT MEDIUM
Source text for Eikon: ID:nGNE9d6hKT
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies